Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.

Ostrominski JW et al.

NCBI PubMed Central · Papers · License: Open Access

machine learning systems

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 266912
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.